Iright
BRAND / VENDOR: Biolegend

Biolegend, 430804, ELISA MAX™ Deluxe Set Mouse IFN-γ, 5plates

CATALOG NUMBER: 430804
السعر العادي$0.99
/
  • ddddd

    99 xxxxxx

  • الطلب مؤجل، سيتم الشحن قريباً

This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.

Product Description

ELISA Development Systems Engineered for Sensitive, Precise and Reliable Serum and Plasma Cytokine Quantitation BioLegend's ELISA MAX™ Sets provide all the time-savings, convenience and performance of a high-end, commercial ELISA kit for a fraction of the price! BioLegend's ELISA MAX™ Sets, in two appealing formats, address the need for sensitivity, accuracy, dependability, and versatility of an ELISA development system, while providing maximum cost effectiveness, value, and ease of use. Both the ELISA MAX™ Set Standard and ELISA MAX™ Set Deluxe are specifically engineered for accurate recovery and measurement of analytes in complex fluids, such as serum and plasma (as well as activated cell cultures) without any interference by confounding serum factors, such as heterophilic antibody or rheumatoid factor.
5plates
Verified Reactivity: Mouse
Application: ELISA
Application Notes: The assay kits will no longer include ELISA microwell plates. Recommended microwell plates can be purchased separately under Cat. No. 423501. Please contact your BioLegend sales representative for bulk pricing quotations.
Application References(PubMed link indicates BioLegend citation): Lau AH, et al. 2006. J. Leukoc. Biol. 79:941. Inoue Y, et al. 2007. J. Immunol. 179:764. Perchonock CE, et al. 2007. J. Immunol. 179:1768. Perruche S, et al. 2009. J. Immunol. 183:953. PubMed Tallima H, et. al. 2009. Cytokine 48:239. PubMed Zhang Y, et al. 2010. Infect Immun. 78:2329. PubMed El Ridi R, et al. 2010. Microbes Infect. epub. PubMed McPhee JB, et al. 2010. Infect Immun. PubMed Yu M, et al. 2011. Vaccine. 29:2429. PubMed Puangpetch A, et al. 2012. Clin Vaccine Immunol. 19:675. PubMed.
Product Citations: Klement JD, et al. 2018. J Clin Invest. 128:5549. PubMed Nakka K, et al. 2022. Science. 377:666. PubMed Tubiana J, et al. 2022. Cell Rep. 41:111512. PubMed Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed Madrid-Paulino E, et al. 2022. J Leukoc Biol. 112:475. PubMed Luo WJ, et al. 2022. Elife. 11: . PubMed Cheng P, et al. 2023. Pharmacol Res. 188:106643. PubMed Bhardwaj M, et al. 2023. J Clin Invest. :. PubMed Sillibourne JE, et al. 2022. Biotechniques. 72:143. PubMed Mooney JP, et al. 2022. Wellcome Open Res. 7:134. PubMed Zhou T, et al. 2020. Nature. 583:609. PubMed Puangpetch A, et al. 2012. Clin Vaccine Immunol. 1.260416667. PubMed Perruche S, et al. 2009. J Immunol. 183:953. PubMed Chen M, et al. 2022. J Nanobiotechnology. 20:273. PubMed Xu B, et al. 2021. Front Immunol. 11:583510. PubMed Radwanska M, et al. 2021. Vaccines (Basel). 9:. PubMed Yu M, Vajdy M 2011. Vaccine. 29:2429. PubMed Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed Puca E, et al. 2020. J Gastrointest Oncol. 1.015972222. PubMed Kohn M, et al. 2021. Front Immunol. 580594:12. PubMed Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed Sun Z, et al. 2020. Front Immunol. 1.568055556. PubMed McPhee J, et al. 2010. Infect Immun. 78:3529. PubMed Daher C, et al. 2019. Cancer Immunol Res. 1.575694444. PubMed Park GT, et al. 2021. Mar Drugs. 19:. PubMed Leroux LP, et al. 2020. Front Cell Infect Microbiol. 0.755555556. PubMed Wei W, et al. 2022. mSystems. 7:e0046922. PubMed Li Y, et al. 2021. Sci Transl Med. 13:. PubMed Park GT, et al. 2019. Front Immunol. 10:2095. PubMed Wang J, et al. 2022. J Clin Invest. :. PubMed Ci T, et al. 2020. Sci Adv. 6:00. PubMed Shiozawa S, et al. 2022. iScience. 25:103537. PubMed Zeng Q, et al. 2022. iScience. 25:105151. PubMed Fernandes RA, et al. 2020. Nature. 779:586. PubMed Bliska Y 2010. Infect Immun. 78:2359. PubMed Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed Abdelfattah N, et al. 2022. Nat Commun. 13:767. PubMed Garrido V, et al. 2021. Mol Syst Biol. 17:e10145. PubMed Minns D, et al. 2021. Nat Commun. 12:1285. PubMed Lanfermann C, et al. 2021. Vaccines (Basel). 9:. PubMed Gu BH, et al. 2022. Biomedicines. 10:. PubMed Lanfermann C, et al. 2021. Vaccines (Basel). 9:. PubMed Shi D, et al. 2022. Nat Commun. 13:5644. PubMed Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed Waaler J, et al. 2020. Commun Biol. 3:196. PubMed Reed MD, et al. 2020. Nature. 577:249. PubMed Chaudhari R, et al. 2021. Nanomaterials (Basel). 11:. PubMed
Sensitivity: 4 pg/mL
Standard Range: 15.6-1,000 pg/mL
Cell Sources: CD8+ and CD4+ T cells, NK cells
Cell Type: Tregs
Biology Area: Immunology, Innate Immunity, Neuroinflammation, Neuroscience
Molecular Family: Cytokines/Chemokines
Gene ID: 15978
UniProt: View information about IFN-gamma on UniProt.org
Regulatory Status: RUO
Other Names: IFN-g ELISA Kit
Q: Do the ELISA MAX™ Deluxe Sets come with plates?
A: No, ELISA MAX™ Deluxe Sets do not come with plates. Coating Buffer and Assay Diluent (for blocking and dilutions) are included in these sets. Plates can be ordered separately (Cat No. 423501), and instructions for coating the plates are in the sets’ product manuals.


Order Guidelines

1. Price & Stock Available on Request. 📧Click to send email to: service@iright.com

2. Please DO NOT make payment before confirmation.

3. Minimum order value of $1,000 USD required.

Collaboration

Tony Tang

📧Email: Tony.Tang@iright.com

📱Mobile/WhatsApp/Wechat: +86-17717886924